Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation

被引:88
作者
Hui, AY [1 ]
Chan, HLY
Leung, NWY
Hung, LCT
Chan, FKL
Sung, JJY
机构
[1] Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China
[2] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA
关键词
chronic hepatitis B; decompensation; survival;
D O I
10.1097/00004836-200205000-00018
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Goals: To determine the 2-year survival and prognostic indicators of hepatitis B virus-related cirrhosis after the onset of hepatic decompensation. Background: Chronic hepatitis B (CHB) patients with cirrhosis and resultant hepatic decompensation have reduced survival. However, the natural history of these patients has not been well characterized in previous studies. Better understanding of survival and prognostic indicators is essential in management of these patients, especially in deter-mining who should be candidates for orthotopic liver transplantation, Study: This is a retrospective longitudinal study of 96 patients with CHB-related cirrhosis after the onset of hepatic decompensation. The overall survival was ascertained. and clinical and laboratory variables were analyzed. Significant prognostic indicators for survival at 2 years were determined using univariate and multivariate analyses with Cox regression model. Results: The overall survival was 80% at 2 years after onset of decompensation. With univariate and multivariate analyses, hepatic encephalopathy and hypoalbuminemia less than 2.8 g/dL were significant prognostic indicators of poor survival probability. The hazard ratios were 5.22 (95% confidence interval. 1.67-16.3) and 8.57 (95% confidence interval. 1.94-37.8), respectively. Patients with hypoalbuminemia less than 2.8 g/dL had a 2-year survival of only 62%. Conclusions: Our study showed that of CHB patients who de,, eloped the first episode of hepatic decompensation, those with hepatic encephalopathy or significant hypoalbuminemia or both have worse prognoses. They should be considered potential candidates for liver transplantation.
引用
收藏
页码:569 / 572
页数:4
相关论文
共 21 条
[11]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[12]   Beneficial effects lamivudine in hepatitis B virus-related decompensated cirrhosis [J].
Kapoor, D ;
Guptan, RC ;
Wakil, SM ;
Kazim, SN ;
Kaul, R ;
Agarwal, SR ;
Raisuddin, S ;
Hasnain, SE ;
Sarin, SK .
JOURNAL OF HEPATOLOGY, 2000, 33 (02) :308-312
[13]  
LIAW YF, 1989, LIVER, V9, P235
[14]   THE DEVELOPMENT OF CIRRHOSIS IN PATIENTS WITH CHRONIC TYPE-B HEPATITIS - A PROSPECTIVE-STUDY [J].
LIAW, YF ;
TAI, DI ;
CHU, CM ;
CHEN, TJ .
HEPATOLOGY, 1988, 8 (03) :493-496
[15]   Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B [J].
Liaw, YF ;
Leung, NWY ;
Chang, TT ;
Guan, R ;
Tai, DI ;
Ng, KY ;
Chien, RN ;
Dent, J ;
Roman, L ;
Edmundson, S ;
Lai, CL .
GASTROENTEROLOGY, 2000, 119 (01) :172-180
[16]   HEPATITIS-B - GLOBAL IMPORTANCE AND NEED FOR CONTROL [J].
MAYNARD, JE .
VACCINE, 1990, 8 :S18-S20
[17]  
MERKEL C, 1989, AM J GASTROENTEROL, V84, P717
[18]   Posttransplantation prevention and treatment of recurrent hepatitis B [J].
Rizzetto, M ;
Marzano, A .
LIVER TRANSPLANTATION, 2000, 6 (06) :S47-S51
[19]  
SALERNO F, 1993, AM J GASTROENTEROL, V88, P514
[20]   Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin [J].
Terrault, NA ;
Zhou, S ;
Combs, C ;
Hahn, JA ;
Lake, JR ;
Roberts, JP ;
Ascher, NL ;
Wright, TL .
HEPATOLOGY, 1996, 24 (06) :1327-1333